Replies to post #8987 on BioSante Pharmaceuticals, Inc. (BPAX)

[re-actor]

As I read the patent:

Methods for decreasing the risk of cardiovascular events in postmenopausal women having a high risk for a cardiovascular event are provided. In particular, methods for decreasing the risk of cardiovascular events in postmenopausal woman at high risk for cardiovascular events by administering to the woman a therapeutically effective amount of an androgen, whereby administering the androgen decreases the risk of cardiovascular events in the woman compared to untreated postmenopausal woman at high risk for cardiovascular events are provided.

Then:

Claim:
29. The method according to claim 1, wherein the woman is surgically postmenopausal or naturally postmenopausal.

And:

[0029] As used herein, "high risk of cardiovascular events" means a woman has a minimum of a 2-point cardiovascular disease risk factor as determined by the following point scale: 1) age 60 to less than 70 years (1 point), 2) 70 years or greater (2 points), 3) diabetes mellitus (2 points), 4) presently smoking at least 10 cigarettes/day (or the equivalent, .....) etc.


~Edit: That would make for any 'post menopausal' woman having diabetes alone, or older than 70.

Yes?

[PennyStockInvestor]

Wow! Take a look at all of these various Cancer Vaccines that BPAX currently has in phase 1 & 2 clinical trials. This stock is definately underrated in my opinion.

http://www.biosantepharma.com/Cancer-Vaccines.php